HER2 Positive Gastric Cancer Market is expected to be valued at US$ 1779.8 million by 2033, at a CAG
The global HER2 Positive Gastric Cancer Market is currently valued at US$ 1261.8 million in 2023, with a CAGR of 3.5% expected. Because of technological advancements in healthcare, the market is expected to reach US$1779.8 million by 2033.“Increased disease burden and pipeline candidate approval are likely to drive...